Waters Corporation Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Waters Corporation stock issued during period, value, stock options exercised for the quarter ending 2026-07-04 was $9.00M, a 800.00% increase year-over-year.
- Waters Corporation stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was $2.58M, a 9.77% decline year-over-year.
- Waters Corporation stock issued during period, value, stock options exercised for the quarter ending 2025-09-27 was $62.00K, a 91.58% decline year-over-year.
- Waters Corporation stock issued during period, value, stock options exercised for the quarter ending 2025-06-28 was $1.00M, a 80.24% decline year-over-year.
- Waters Corporation stock issued during period, value, stock options exercised for fiscal 2025 was $10.44M, a 50.75% decline from fiscal 2024.
- Waters Corporation stock issued during period, value, stock options exercised for fiscal 2024 was $21.20M, a 20.23% increase from fiscal 2023.
- Waters Corporation stock issued during period, value, stock options exercised for fiscal 2023 was $17.64M, a 44.33% decline from fiscal 2022.
- Waters Corporation stock issued during period, value, stock options exercised for fiscal 2022 was $31.68M, a 31.23% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2026-07-04 | $9.00M 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $2.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $10.44M 10-K · filed 2026-02-23 |
| 2025-09-27 | $62.00K 10-Q · filed 2025-11-04 | $10.92M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-28 | $1.00M 10-Q · filed 2026-08-11 | $11.59M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-29 | $7.00M 10-Q · filed 2026-05-12 | $15.65M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $2.86M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $21.20M 10-K · filed 2026-02-23 |
| 2024-09-28 | $736.00K 10-Q · filed 2025-11-04 | $27.61M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-06-29 | $5.06M 10-Q · filed 2025-08-04 | $31.96M derived: sum of 4 quarters · filed 2026-02-23 |
| 2024-03-30 | $12.55M 10-Q · filed 2025-05-06 | $29.22M derived: sum of 4 quarters · filed 2026-02-23 |
| 2023-12-31 | $9.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-23 | $17.64M 10-K · filed 2026-02-23 |
| 2023-09-30 | $5.08M 10-Q · filed 2024-11-01 | $11.92M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-07-01 | $2.32M 10-Q · filed 2024-07-31 | $9.35M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-04-01 | $969.00K 10-Q · filed 2024-05-07 | $21.55M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $3.56M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $31.68M 10-K · filed 2025-02-25 |
| 2022-10-01 | $2.51M 10-Q · filed 2023-11-07 | $28.07M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-07-02 | $14.52M 10-Q · filed 2023-08-02 | $32.97M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-04-02 | $11.09M 10-Q · filed 2023-05-09 | $42.03M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $46.06M 10-K · filed 2024-02-27 |
| 2021-10-02 | $7.40M 10-Q · filed 2022-11-03 | $81.67M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-07-03 | $23.59M 10-Q · filed 2022-08-04 | $86.31M derived: sum of 4 quarters · filed 2023-02-27 |
| 2021-04-03 | $15.13M 10-Q · filed 2022-05-05 | $63.51M derived: sum of 4 quarters · filed 2023-02-27 |
| 2020-12-31 | $35.56M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $58.50M 10-K · filed 2023-02-27 |
| 2020-09-26 | $12.04M 10-Q · filed 2021-11-04 | $40.19M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-27 | $779.00K 10-Q · filed 2021-08-05 | $30.52M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-28 | $10.13M 10-Q · filed 2021-05-06 | $29.74M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $17.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $45.72M 10-K · filed 2022-02-24 |
| 2019-09-28 | $2.38M 10-Q · filed 2020-10-28 | $36.51M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-29 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $39.87M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-30 | $26.10M 10-Q · filed 2020-04-29 | $47.95M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $8.03M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | $44.55M 10-K · filed 2021-02-24 |
| 2018-09-29 | $5.74M 10-Q · filed 2019-10-30 | |
| 2018-06-30 | $8.07M 10-Q · filed 2019-07-31 | |
| 2018-03-31 | $22.71M 10-Q · filed 2019-05-03 | |
| 2017-12-31 | $90.91M 10-K · filed 2020-02-25 | |
| 2016-12-31 | $55.91M 10-K/A · filed 2019-03-01 | |
| 2015-12-31 | $46.56M 10-K · filed 2018-02-27 | |
| 2014-12-31 | $68.82M 10-K · filed 2017-02-24 | |
| 2013-12-31 | $64.14M 10-K · filed 2016-02-26 | |
| 2012-12-31 | $24.21M 10-K · filed 2015-02-27 | |
| 2011-12-31 | $56.00M 10-K · filed 2014-02-27 | |
| 2010-12-31 | $97.13M 10-K · filed 2013-02-26 | |
| 2009-12-31 | $15.86M 10-K · filed 2012-02-24 | |
| 2008-12-31 | $25.24M 10-K · filed 2011-02-25 | |
| 2007-12-31 | $88.54M 10-K · filed 2010-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| AGILENT TECHNOLOGIES, INC. (A) | United States | $48.720B | 27.14 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |